Back to News
Market Impact: 0.2
Vector Science Invests In Gary Payton's Scoreboard To Develop Peptide Products For Athletes
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Vector Science and Therapeutics Corp. (PAIN.V), which develops drug-delivery technology and pharma-grade peptide manufacturing, entered into a strategic relationship with performance wellness company Scoreboard Inc. The provided article text contains no deal terms, financial figures, or further details about the relationship.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
PAIN0.45
More News
- The world needs Ukraine’s grain. Its farmers are running out of reasons to plant
- Why is the Chinese stock market missing the AI rally
- Why is T-Mobile stock tumbling today?
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback
- SpaceX makes big move into wireless. These once 'obsolete' tech stocks could benefit
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight